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ABSTRACT Potatoes are cultivated in southwest Greenland without the use of pesticides and with limited crop rotation. Despite
the fact that plant-pathogenic fungi are present, no severe-disease outbreaks have yet been observed. In this report, we document
that a potato soil at Inneruulalik in southern Greenland is suppressive against Rhizoctonia solani Ag3 and uncover the suppres-
sive antifungal mechanism of a highly potent biocontrol bacterium, Pseudomonas fluorescens In5, isolated from the suppressive
potato soil. A combination of molecular genetics, genomics, and matrix-assisted laser desorption ionization–time of flight
(MALDI-TOF) imaging mass spectrometry (IMS) revealed an antifungal genomic island in P. fluorescens In5 encoding two non-
ribosomal peptides, nunamycin and nunapeptin, which are key components for the biocontrol activity by strain In5 in vitro and
in soil microcosm experiments. Furthermore, complex microbial behaviors were highlighted. Whereas nunamycin was demon-
strated to inhibit the mycelial growth of R. solani Ag3, but not that of Pythium aphanidermatum, nunapeptin instead inhibited
P. aphanidermatum but not R. solani Ag3. Moreover, the synthesis of nunamycin by P. fluorescens In5 was inhibited in the pres-
ence of P. aphanidermatum. Further characterization of the two peptides revealed nunamycin to be a monochlorinated
9-amino-acid cyclic lipopeptide with similarity to members of the syringomycin group, whereas nunapeptin was a 22-amino-
acid cyclic lipopeptide with similarity to corpeptin and syringopeptin.
IMPORTANCE Crop rotation and systematic pest management are used to only a limited extent in Greenlandic potato farming.
Nonetheless, although plant-pathogenic fungi are present in the soil, the farmers do not experience major plant disease out-
breaks. Here, we show that a Greenlandic potato soil is suppressive against Rhizoctonia solani, and we unravel the key biocon-
trol components for Pseudomonas fluorescens In5, one of the potent biocontrol bacteria isolated from this Greenlandic suppres-
sive soil. Using a combination of molecular genetics, genomics, and microbial imaging mass spectrometry, we show that two
cyclic lipopeptides, nunamycin and nunapeptin, are important for the biocontrol activity of P. fluorescens In5 both in vitro and
in microcosm assays. Furthermore, we demonstrate that the synthesis of nunamycin is repressed by the oomycete Pythium
aphanidermatum. Overall, our report provides important insight into interkingdom interference between bacteria and fungi/
oomycetes.
Received 15 January 2015 Accepted 11 February 2015 Published 17 March 2015
Citation Michelsen CF, Watrous J, Glaring MA, Kersten R, Koyama N, Dorrestein PC, Stougaard P. 2015. Nonribosomal peptides, key biocontrol components for Pseudomonas
fluorescens In5, isolated from a Greenlandic suppressive soil. mBio 6(2):e00079-15. doi:10.1128/mBio.00079-15.
Editor E. Peter Greenberg, University of Washington
Copyright © 2015 Michelsen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-ShareAlike 3.0 Unported
license, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
Address correspondence to Peter Stougaard (queries on microbial genetics work), psg@plen.ku.dk, or Pieter C. Dorrestein (queries on imaging MS), pdorrestein@ucsd.edu.
Agriculture in subarctic Greenland is possible without pesti-cides and with limited crop rotation despite the presence of
plant-pathogenic fungi. For example, potatoes cultivated in a
small single field at the Agricultural Consulting Services inQaqor-
toq for almost 50 years showed no severe incidence of diseases
such as potato late blight (K. Høegh, personal communication).
One plausible explanation is that these Greenlandic soils are dis-
ease suppressive, i.e., they contain beneficial microbes that posi-
tively affect the growth and health of plants (1, 2). Suppressive
soils have been described from several parts of the world, includ-
ing Fusarium wilt-suppressive soils from Chateaurenard (France)
and the Salinas Valley (United States), potato scab-suppressive
soils fromWashington (United States), and suppressive sugar beet
soils (the Netherlands) (2, 3). Beneficial microorganisms respon-
sible for suppression of fungal growth, the so-called biological
control agents (BCAs), have been discovered among bacteria of
several genera, e.g., Bacillus, Alcaligenes, Burkholderia, Agrobacte-
rium, and Pseudomonas (1–4). Of these, fluorescent pseudomon-
ads have been investigated in the greatest detail, and antifungal
compounds, including phenazines, pyoluteorin, phloroglucinols,
pyrrolnitrin, hydrogen cyanide (HCN), and nonribosomal pep-
tides (NRPs), have been identified (5).
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A Pseudomonas strain with high antifungal activity was previ-
ously isolated from a potato field at Inneruulalik, southernGreen-
land (6). This bacterium, Pseudomonas fluorescens In5, inhibited a
wide range of pathogenic fungi and oomycetes in vitro in a
temperature-dependent manner, i.e., showing higher activities at
lower temperatures (6). Previous attempts to identify antifungal
compounds such as phenazines, pyoluteorin, phloroglucinols,
and pyrrolnitrin, or the genes encoding such compounds in
P. fluorescens In5, were unsuccessful. The only putative antifungal
compound identified was HCN, but genetic analysis indicated
that an unknown NRP might also be involved in the antifungal
activity of this strain (6, 7). The actual NRP, however, was never
identified or isolated.
In this study, we unraveled the antifungal mechanism of the
disease-suppressive P. fluorescens In5 strain using a combination
of in vitro agar plate assays, soil microcosm experiments, molecu-
lar genetics, genomics, and matrix-assisted laser desorption ion-
ization–time of flight (MALDI-TOF) imaging mass spectrometry
(IMS) analyses. We show that the main biocontrol ability of
P. fluorescens In5 is mediated by two lipopeptides with distinct
fungal inhibition activities depending on the target fungus or oo-
mycete.
RESULTS
Potato soil from Inneruulalik in southern Greenland is disease
suppressive. Soil samples were collected from a potato field at
Inneruulalik in southern Greenland. According to the farmer, po-
tatoes were cultivated in the same plot for at least 10 consecutive
years without any incidence of severe diseases. The disease-
suppressive properties of the soil were investigated using in vitro
soil microcosm experiments with seedlings of tomato (a member
of the same plant family as potatoes, Solanaceae) and the plant-
pathogenic basidiomycete Rhizoctonia solani Ag3 causing, e.g.,
stem rot and tuber black scurf of potatoes. Seedlings planted into
the Inneruulalik soil inoculated with R. solani Ag3 mycelium did
not show any damping-off symptoms, whereas a heat treatment of
the soil (80°C for 1 h), followed byR. solaniAg3 inoculation, led to
severely affected seedlings (Fig. 1). In addition, the disease-
suppressive properties of the heat-treated soil could be almost
completely recovered by mixing in a small (10%) amount of the
untreated soil (Fig. 1), which suggests that the Inneruulalik soil is
suppressive against R. solani Ag3 and that the suppressive mech-
anism is of microbiological origin. Metagenomic DNA was iso-
lated from the Inneruulalik suppressive soil, and pyrosequencing
generated a total of 30,747 high-quality sequences revealingmem-
bers of the phyla Proteobacteria, Bacteroidetes, Actinobacteria, and
Acidobacteria to be the most abundant bacteria in the soil micro-
biome (see Table S1 in the supplemental material). Members of
the bacterial genera Pseudomonas, Bacillus, Paenibacillus, Strepto-
myces, and Burkholderia have previously been described for their
biocontrol activities (8–11); however, the culture-independent
pyrosequencing analysis showed that these bacterial genera con-
stituted only a small fraction of the total diversity in the Inneruu-
lalik soil (see Table S2). Previously, a potent antifungal pseu-
domonad, P. fluorescens In5, was identified from the Inneruulalik
potato soil using culture-based approaches (6); hence, this bio-
control bacterium was the subject of the subsequent studies.
Molecular genetics of P. fluorescens In5 reveal an antifungal
genomic island encoding nonribosomal peptides with distinct
antifungal activities.To identify genes inP. fluorescens In5 encod-
ing antifungal compounds, a Tn5 transposon mutant library was
constructed and the approximately 1,500 mutants were arranged
inmicrotiter plate format and screened for loss ofmycelial growth
inhibition of R. solani Ag3 or Pythium aphanidermatum (an oo-
mycete causing leak syndrome of potatoes) in vitro. One mutant,
Tn1, failed to inhibit mycelial growth of R. solani Ag3, whereas
inhibition of P. aphanidermatumwas slightly increased compared
to the level seen with wild-type strain In5 (Fig. 2A; see also Fig. S1
in the supplemental material). DNA sequence analysis of the in-
sertion site showed that the transposon had inserted into an open
reading frame (ORF), nunE, encoding a putative NRP (Fig. 3).
Interestingly, a closer examination of the whole-genome sequence
of P. fluorescens In5 revealed that the genomic region around the
transposon insertion site contained a number of ORFs with sim-
ilarities to known NRP genes from P. syringae pv. syringae B728a,
Cit7, and 642 and from Pseudomonas sp. SHC52 (Fig. 3; see also
Table S3). The amino acid sequence encoded by nunE and that
encoded by the adjacent nunDORF showed high similarity to the
products of the thanamycin synthesis gene cluster from Pseu-
domonas sp. SHC52 (60% identity [Id] to ThaA and 76% Id to
ThaB, respectively) as well as similarity to those of the syringomy-
cin synthesis gene cluster (syrE) from P. syringae pv. syringae
B728a, Cit7, and 642 (approximately [approx.] 30% to 40% Id)
(Fig. 3; see also Table S3). In addition to nunD and nunE, the
nunB1 and nunB2 gene products showed high similarity to the
thaC1 and thaC2 gene products from Pseudomonas sp. SHC52
(73% and 87% Id, respectively) and to syrB1 and syrB2 gene prod-
ucts from P. syringae strains B728a, Cit7, and 642 (approx. 70% to
88% Id) (Fig. 3; see also Table S3). SyrB1/ThaC1 and SyrB2/
ThaC2 are believed to be involved in selection and activation of
Thr-9 and in chlorination of the nonribosomal peptides syringo-
mycin and thanamycin, respectively (3, 12, 13). Furthermore, the
nunC gene product showed high similarity to ThaD from Pseu-
domonas sp. SHC52 (69% Id) and to SyrC from P. syringae strains
B728a, Cit7, and 642 (approx. 69% to 70% Id), whichmediate the
transfer of 4-Cl-L-Thr from the NRP-T1 domain to the NRP-T8,9
domain as described in the syringomycin synthesis assembly line
(12). The peptide encoded by nunB1, nunB2, nunC, nunD, and
nunE was denoted “nunamycin” (in Greenlandic, Nuna Earth/
land and Kalaallit Nunaat Greenland).
Next to the nunamycin biosynthesis gene cluster, other ORFs
FIG 1 Soil microcosm experiment. Presprouted tomato seedlings were
planted in the Inneruulalik suppressive soil (S), in the Inneruulalik soil heat
treated at 80°C (C, conducive), and in heat-treated soil mixed with the sup-
pressive soil (9:1 [wt/wt]) (CS). Damping-off symptoms of infected seedlings
caused by R. solani Ag3 were scored visually and expressed as percentages of
disease incidence (means standard errors of the means [SEM], n 4). The
asterisk indicates a statistically significant difference from the suppressive soil
(S) (P 0.05, Tukey’s HSD test).
Michelsen et al.
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encoding putativeNRPswere present. ThreeORFs denoted nupA,
nupB, and nupC displayed similarity to the syringopeptin biosyn-
thesis gene cluster from P. syringae pv. syringae B728a (between
36% and 47% Id) (Fig. 3; see also Table S3 in the supplemental
material), whereas a corresponding gene cluster was not identified
in Pseudomonas sp. SHC52 due to a truncated DNA sequence
from this isolate. The putative peptide encoded by the nupA,
nupB, and nupC gene cluster was denoted nunapeptin. In addition
to the two nun and nup gene clusters, the antifungal genomic
island in P. fluorescens In5 also contained the genes nupD, pseA to
pseC (pseA-C), and pseE-F, which in P. syringae have been associ-
ated with regulation and export of peptides (Fig. 3; see also Ta-
ble S3) (14). The gene order of the In5 antifungal genomic island
was identical to that of P. syringae pv. syringae B728a, but the
thaC1, thaC2, and thaD genes in Pseudomonas sp. SHC52 were
located downstream of the major NRP genes thaA and thaB
(Fig. 3).
Gene replacement mutants Gr1 (mutated in nunD) and Gr2
(mutated in nupB) as well as a double mutant, Tn1Gr2, carrying
both themutation in Tn1 (mutated in nunE) and that inGr2, were
constructed in P. fluorescens In5 (Fig. 3) and analyzed for antifun-
gal activities in vitro on agar plates. Mutant Gr1 displayed activity
similar to that seen with mutant Tn1, i.e., significantly reduced
inhibition of R. solani Ag3 mycelial growth compared to that of
FIG 2 (A) Inhibition of R. solani Ag3 (i) or P. aphanidermatum (ii) mycelial growth by P. fluorescens In5 (wt) and the P. fluorescens In5-derived mutant strains,
Tn1 (the nunEmutant), Gr1 (the nunDmutant), Gr2 (the nupBmutant), and Tn1 Gr2 (the nunE nupB double mutant). In all cases, the bacteria are seen in the
central colony on the agar plate surrounded by four identical mycelium plugs. Inhibition of R. solani Ag3 is indicated by white arrowheads, whereas inhibition
of P. aphanidermatum is indicated by black arrowheads. (B) MALDI-TOF imaging mass spectrometry images of nunamycin (NM; red) and nunapeptin (NP;
green) produced byP. fluorescens In5 (wt) and theP. fluorescens In5-derivedmutant strains, Tn1 andGr1, coculturedwithR. solaniAg3 (i) orP. aphanidermatum
(ii). (C) Table summarizing production of nunamycin (NM) and nunapeptin (NP) by the P. fluorescens In5 wt and mutant strains Tn1, Gr1, Gr2, and Tn1Gr2
as evaluated by MALDI-TOF IMS and/or MS analysis., production of peptide;, no production of peptide.
FIG 3 Map of the antifungal genome cluster of P. fluorescens In5 (A) and closest relatives Pseudomonas sp. SHC52 (GenBank accession no. HQ888764) (B) and
P. syringae pv. syringae B728a (GenBank accession number NC_007005) (C). Open triangles show the gene replacement mutations corresponding to Gr1 and
Gr2; the filled triangle shows the transposon mutation corresponding to Tn1. Grey arrow boxes with a boldface capital E denote genes involved in export; open
arrow boxes with a boldface capital R denote genes involved in regulation.
Antifungal Peptides from Pseudomonas
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wild-type strain In5, whereas inhibition of P. aphanidermatum
was slightly increased (Fig. 2A; see also Fig. S1 in the supplemental
material). The biocontrol activity of the nunE mutant, Tn1, was
further studied in soil microcosm experiments, and results re-
vealed a substantially reduced ability to protect tomato seedlings
againstR. solaniAg3 compared to the wild-type In5 strain (Fig. 4).
The nupB mutant, Gr2, had completely lost the ability to inhibit
P. aphanidermatum mycelial growth, whereas the same low level
of inhibition against R. solani Ag3 as that seen with the mutants
Gr1 and Tn1 was observed (Fig. 2A; see also Fig. S1), indicating
that, in contrast to the nun genes, nupB plays a role in biocontrol
of P. aphanidermatum. Furthermore, the Tn1Gr2 double mutant
showed virtually no in vitro inhibition activity against R. solani
Ag3 or P. aphanidermatum (Fig. 2A; see also Fig. S1).
Identification of nonribosomal peptides produced byP.fluo-
rescens In5 using MALDI-TOF imaging mass spectrometry. In
order to bypass laborious and time-consuming conventional
peptide purification methods, we used matrix-assisted laser des-
orption–ionization time of flight (MALDI-TOF) imaging mass
spectrometry (IMS) to identify the antifungal peptides encoded
by the antifungal genomic island in P. fluorescens In5. Ions of
interest were selected by superimposing the false-colored ion dis-
tribution map from the IMS analysis onto an optical image of the
bacterium-fungus interaction and searching for ions with a strong
presence within the area of fungal inhibition (Fig. 2B and C). In
cocultures of theP. fluorescens In5wild type andR. solaniAg3, ions
with a mass of m/z 1,138 and a family of m/z 2,023 to 2,075, with
the highest intensity observed atm/z 2,060, were detected, whereas
mutant strains Tn1 and Gr1 produced only the m/z 2,060 ion
(Fig. 2B and C). These results showed that the m/z 1,138 ion cor-
responded to the nunamycin peptide and indicated that the m/z
2,060 ion corresponded to the nunapeptin peptide. MALDI-TOF
mass spectrometry (MS) analysis of the P. fluorescens In5wild type
and the mutant strains further confirmed the production of both
nunamycin and nunapeptin by the In5 wild-type strain, whereas
the mutant strains, Tn1 and Gr1, produced only nunapeptin and,
notably, the mutant strains, Gr2 and Tn1Gr2, showed no produc-
tion of either nunamycin or nunapeptin (Fig. 2C; see also Fig. S2
in the supplemental material).
Surprisingly, we noticed in the MALDI-TOF IMS analysis
that cocultures with P. fluorescens In5 and P. aphanidermatum
showed the presence only of nunapeptin (i.e., m/z 2,060 ion) and
not of nunamycin (i.e., m/z 1,138 ion) (Fig. 2B), indicating that
P. aphanidermatum inhibited the synthesis of nunamycin in strain
In5. Corroborating the results from coculture experiments, the
crude peptide extract from P. fluorescens In5 containing both nu-
namycin and nunapeptin inhibited mycelial growth of both R. so-
laniAg3 andP. aphanidermatum, whereas the purifiednunamycin
peptide inhibited R. solani Ag3 but not P. aphanidermatum, and
the purified nunapeptin in contrast showed inhibition of
P. aphanidermatum but not of R. solani Ag3 (Fig. 5).
The expression of nunamycin and nunapeptin was analyzed
over time using MALDI-TOF MS. The two ions m/z 1,138 and
2,060, corresponding to nunamycin and nunapeptin, respectively,
first appeared 12 h after inoculation of P. fluorescens In5, with a
maximum mass signal observed at 48 to 72 h (Fig. 6). In the two
nunmutants, Tn1 and Gr1, them/z 1,138 ion was absent (Fig. 6).
After 7 days, the m/z 1,138 ion was no longer visible, whereas the
m/z 2,060 ion was present but at a lower intensity (Fig. 6).
Molecular structures of nunamycin and nunapeptin reveal
two cyclic lipopeptides. The molecular structures of nunamycin
and nunapeptin are proposed on the basis of a combination of
nuclear magnetic resonance (NMR)- and mass spectrometry
(MS)-based methods (Fig. 7). For nunamycin, initial analysis of
the parent peak at m/z 1,138.54 by high-resolution mass spec-
trometry indicated the presence of a single chlorine atom within
FIG 4 Soil microcosm experiment. The microcosm experiment was carried
out with soil containing R. solani Ag3 (R) that was inoculated with P. fluore-
scens strain In5 wt and R. solani Ag3 (In5-R) or with mutant strain Tn1 and R.
solani Ag3 (Tn1-R) and maintained at 15°C (A) or 20°C (B); the results were
compared to those seenwith untreated control soil (columnC), soil inoculated
with P. fluorescens In5 wt (In5) or mutant strain Tn1 (Tn1). Damping-off
symptoms of infected seedlings caused by R. solani Ag3 were scored visually
and expressed as percentages of disease incidence (means  SEM, n  4).
Asterisks indicate statistically significant differences from the control treat-
ment (column C) (P 0.05, Tukey’s HSD test).
FIG 5 Inhibition of R. solani Ag3 (i) or P. aphanidermatum (ii) mycelial
growth by 10g crude peptide extract derived from the P. fluorescens In5 wild
type containing both the nunamycin and nunapeptin peptides (NMNP);
10 g of the purified nunamycin (NM) or nunapeptin (NP) peptides was
spotted on sterile pieces of filter paper in the center of the agar plate sur-
rounded by four identical mycelium plugs. Inhibition of R. solani Ag3 is indi-
cated by white arrowheads, whereas inhibition of P. aphanidermatum is indi-
cated by black arrowheads.
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the structure due to a 24% increase in the M 2 peak due to the
37Cl isotope of chlorine. Analysis of the gene cluster also showed
the presence of a chlorinase enzyme adjacent to an adenylation
domain capable of loading a 4-Cl threonine residue (see Fig. S3 in
the supplemental material). Analysis of the nunamycin gene clus-
ter and comparisons to the syringomycin and thanamycin gene
clusters indicated a missing A domain in the modular organiza-
tion of the nunamycinNRP (i.e., inmodule 5 as shown in Fig. S3);
at the same time, further annotation of NMR, tandem MS (MS/
MS), and MS/MS/MS data revealed that nunamycin is a cyclic
lipopeptide, consistent with the presence of the 9 amino acid res-
idues Ser-Dab-Gly-Hse-Dab-Thr-Thr-(3-OH)Asp-(4-Cl-Thr)
(see the Fig. 7 legend for definitions of abbreviations) attached to
a 3-hydroxy fatty acid tail (Fig. 7; see also Fig. S3).
Analysis of the nunapeptin gene cluster combinedwithMS/MS
analysis revealed the presence of a 22-amino-acid cyclic lipopep-
tide, i.e., Dhb-Pro-Ala-Ala-Ala-Val-Ala-Dhb-Ser-Val-Ile-Dha-
Ala-Val-Ala-Val-Dhb-Thr-Ala-Dab-Ser-Ile, with strong similarity
to corpeptin and syringopeptin (Fig. 7; see also Fig. S4 in the
supplemental material). By high-resolution mass spectrometry,
the primary ion at m/z 2,045.20 gave a clear sequence tag for
16 amino acid residues with the sequence Pro-Ala-Ala-Ala-Val-
Ala-Dhb-Ser-Val-Ile-Dha-Ala-Val-Ala-Val-Thr. In addition, two
larger fragments at m/z 254.175 and m/z 473.272 appeared in the
mass spectrum. The molecular formula of the m/z 254.175 frag-
ment correlated with a Dhb residue attached to 3-OH dodecanoic
acid (Fig. 7; see also Fig. S4), which is similar to the structure of
syringopeptin and corpeptin (15). The molecular formula for the
m/z 473.272 fragment was consistent with a Thr-Ala-Dab-Ser-Ile
cyclic peptidemoiety (Fig. 7; see also Fig. S4), which is identical to
the cyclic tail of corpeptin (15). The results of two-dimensional
(2D) homo- and heteronuclear NMR experiments supported the
mass spectral interpretation (see Table S4). In addition to the
primary nunapeptin, three analogs were observed in the mass
spectrum of In5 (m/z 2,023.22, m/z 2,037.24, and m/z 2,075.22)
(see Fig. S2). Tandem MS analysis of these analogs showed iden-
tical mass losses for the lipid tail (m/z 254.175) as well as for the
terminal cyclic peptide (m/z 473.272).
DISCUSSION
In certain subarctic fields in Greenland, it is possible to cultivate
potatoes with limited crop rotation and no use of pesticides, even
though plant-pathogenic fungi are present in the soils. Using soil
microcosms, we showed that a potato soil from Inneruulalik in
southern Greenland was able to suppress the growth of the plant-
pathogenic fungus Rhizoctonia solani Ag3. Such suppressive soils
exist worldwide (2), but this report is the first to describe a disease-
suppressive soil from a subarctic region. Antifungal microorgan-
isms from suppressive soils have been shown to comprise several
bacterial genera (2, 8–11), and an analysis of the Inneruulalik soil
by 16S rRNA gene pyrosequencing identified the presence of or-
ganisms belonging to several of these genera, i.e., Pseudomonas,
Bacillus, Paenibacillus, Streptomyces, and Burkholderia. However,
the frequency of organisms of these genera constituted in total less
FIG 6 Time course experiments with the P. fluorescens In5 wild type (A) and
the mutant strains, P. fluorescens Tn1 (B) and P. fluorescens Gr1 (C), cultured
on solid 1/5 PDA. Production of nunamycin (NM) (i.e.,m/z 1,138) andmem-
bers of the nunapeptin family (NP) (i.e.,m/z 2,060) by the bacterial strains was
measured using MALDI-TOF dried-droplet mass spectrometry at 6 h, 12 h,
24 h, 36 h, 48 h, 72 h, 96 h, and 7 days (d) of incubation as indicated by each line
on the y axis. Mass spectra are displayed as stacked heat maps. Each numbered
row is a singlemass spectrumwith peak intensities represented as a color scale,
where low-intensity signals are closer to white and higher-intensity signals are
closer to black as shown in the panel to the right of the spectrum. arb.u.,
arbitrary units.
FIG 7 The proposed structures of nunamycin from P. fluorescens In5 and the analogous peptides thanamycin, cormycin A, and syringomycin (A) and of
nunapeptin from P. fluorescens In5 and the analogous peptides corpeptin A and syringopeptin (B). The abbreviations are as follows: (3-OH)Asp,
3-hydroxyaspartic acid; (4-Cl)Thr, 4-chlorothreonine; Dab, 2,4-diaminobutyric acid; Dhb, dehydrobutyrine; Dha, dehydroalanine; Orn, ornithine; Hse, ho-
moserine. Consensus amino acids are denoted in gray-lined boxes.
Antifungal Peptides from Pseudomonas
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than 1% of all phylotypes, which led us to the assumption that the
bacteria present in the disease-suppressive Inneruulalik soil must
be potent inhibitors of fungal growth. An effective biocontrol bac-
terium, P. fluorescens In5, was previously isolated from the Inne-
ruulalik soil and was found to encode genes for the synthesis of
antifungal compounds, including hydrogen cyanide and a
hitherto-uncharacterized nonribosomal peptide (6, 7).
Nonribosomal peptides isolated from several pseudomonads
using conventional methods such as extraction of active com-
pounds in organic solvents followed by high-pressure liquid chro-
matography (HPLC) fractionation and structure resolution by
NMR and MS have been described previously (16–18). In this
study, we demonstrated that molecular genetics combined with
genomics and MALDI-TOF IMS may facilitate the process of
identification and purification of NRPs and in addition assist in
verifying the presence of the desired compounds within the dif-
ferent extraction and purification steps. Furthermore, this ap-
proach facilitated expression studies of the individual NRPs in
live bacterial-fungal cocultures both spatially and temporally.
MALDI-TOF IMS analysis of P. fluorescens In5 revealed the pres-
ence of two antifungal NRPs in the inhibition zone of R. solani
AG3 and P. aphanidermatum, respectively. These NRPs, denoted
nunamycin and nunapeptin, showed structural resemblance to
syringomycin and syringopeptin from P. syringae and to cor-
mycin A and corpeptin A from P. corrugata (15) as well as to
thanamycin from Pseudomonas sp. SH-C52 (19). Nunamycin
was found to be a chlorinated cyclic lipopeptide composed of
9 amino acid residues, Ser-Dab-Gly-Hse-Dab-Thr-Thr-(3-
OH)Asp-(4-Cl-Thr), with a molecular mass of 1,137.54 Da,
while nunapeptin was produced as a family of cyclic lipopep-
tides of 22 amino acid residues, Dhb-Pro-Ala-Ala-Ala-Val-Ala-
Dhb-Ser-Val-Ile-Dha-Ala-Val-Ala-Val-Dhb-Thr-Ala-Dab-Ser-Ile,
withmolecularmasses ranging from 2,023 to 2,075 Da. The struc-
tures of nunamycin and nunapeptin contained some uncommon
amino acids, such as (3-OH)Asp (3-hydroxyaspartic acid), (4-
Cl)Thr (4-chlorothreonine), Dab (2,4-diaminobutyric acid), Dhb
(dehydrobutyrine), and Dha (dehydroalanine). However, these
amino acids are present in a range of nonribosomal peptides, in-
cluding antimicrobial peptides of the syringomycin, tolaasin, and
syringopeptin families (15).
While the biosynthesis of nunapeptin is catalyzed by three
NRPs (NupA, NupB, and NupC) in a collinear manner, the bio-
synthesis of nunamycin, catalyzed by the three NRPs, NunB1/
NunB2, NunD, and NunE, does not respect the collinearity rule.
For example, a split-module phenomenon was found in the ninth
module in the nunamycin NRP, NunE; the C and T domains were
present, but an A domain was not, which instead was present in
NunB1, as also described for the syringomycin synthase (15). Fur-
thermore, an additional A domain was lacking in module 5 of the
nunamycin NRP NunD. However, chemical analysis showed that
Dab was present as the fifth amino acid in the nunamycin peptide
chain; thus, we speculate that the A domain in module 2 could
function twice. Such module shuffling has been documented be-
fore in NRP-catalyzed peptide synthesis (20).
Transposon and gene replacement mutants, i.e., Tn1, Gr1,
Gr2, and Tn1Gr2, constructed in P. fluorescens In5 confirmed that
nunamycin and nunapeptin are key components for the biocon-
trol ability observed by this strain. However, the two peptides
showed distinct inhibition activities. Nunamycin was found to
play a role primarily in R. solani AG3 mycelial growth inhibition,
whereas nunapeptin was essential for P. aphanidermatum inhibi-
tion. However, when a nunapeptin NRP knockout mutant (Gr2,
mutated in nupB) was analyzed in coculture, this mutant was de-
fective in growth inhibition of both P. aphanidermatum and R. so-
lani Ag3, although the nunamycin biosynthesis was intact. A
closer examination of the nup operon showed the presence of six
genes, nupD, pseA-C, and pseE-F, possibly involved in the efflux of
NRPs (14, 21). Thus, it is likely that the knockout of the nupB gene
in P. fluorescens In5 negatively influences not only the synthesis of
nunapeptin but also the efflux system located downstream of
the nup genes. If expression of the pse genes is affected, this
could inhibit efflux of both the nunapeptin and nunamycin and
consequently also affect the inhibition activity against both
P. aphanidermatum and R. solani Ag3. This hypothesis was sup-
ported by MALDI-TOF MS analysis, which showed no produc-
tion of nunapeptin or nunamycin by this mutant strain.
MALDI-TOF IMS enabled us to study the expression of nuna-
mycin and nunapeptin simultaneously and in relation to interac-
tions between P. fluorescens In5 and R. solaniAg3 or P. aphanider-
matum. Nunamycin and nunapeptin were both expressed in
cocultures of P. fluorescens In5 with R. solani Ag3. However, only
nunapeptin was present in cocultures with P. aphanidermatum,
suggesting that the synthesis of nunamycin in P. fluorescens In5
was inhibited by P. aphanidermatum. Regulation of lipopeptides
and other secondary metabolites in pseudomonads by other or-
ganisms has been reported in several cases. For example, the pro-
duction of secondarymetabolites in P. aeruginosawas found to be
affected by a halogenated furanone compound produced by the
AustralianmacroalgaDelisea pulchra (22), and sugar beet extracts
were shown to affect lipopeptide synthesis in Pseudomonas sp.
DSS73 (23). The exact mechanism by which P. aphanidermatum
inhibited the biosynthesis of nunamycin in P. fluorescens In5 in
this study, however, still needs to be elucidated.
MALDI-TOF MS analysis similarly permitted a study of the
expression of nunamycin and nunapeptin by P. fluorescens In5
wild-type andmutant strains and allowed a time course analysis of
nunamycin and nunapeptin synthesis by P. fluorescens In5. Nuna-
mycin and nunapeptin were first detected 12 h after inoculation,
with signals for the peptides reaching a maximum after 48 to 72 h
of incubation and subsequently decreasing after 7 days of incuba-
tion. This expression profile is different from other lipopeptide
synthesis profiles. For example, inP. fluorescens strain SS101,mas-
setolide A biosynthesis initiates between 12 h and 16 h of incuba-
tion and peaks after 24 h of incubation (24). In Bacillus amyloliq-
uefaciens, synthesis of surfactin and fengycin displayed maximal
production after 10 to 40 h and decreased after 60 h, whereas
bacillomycin D showed maximal intensity after 40 and 60 h (25).
The transient production of nunamycin, however, has previously
been observed with the analogous molecule thanamycin from
Pseudomonas sp. SH-C52 (19).
The results presented in this report demonstrate the powerful
approach of combining in vitro inhibition experiments with mo-
lecular genetics, genomics, andMALDI-TOF IMS analyses. Using
this combination of tools, we were able to unravel the key biocon-
trol factors of a Greenlandic bacterium, P. fluorescens In5, isolated
from a disease-suppressive potato soil in subarctic Greenland, to
elucidate the structure and function of two antifungal lipopep-
tides, and to document that the effective biocontrol ability of
P. fluorescens In5 requires the synthesis of both peptides.
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MATERIALS AND METHODS
Strains and culture conditions. Bacterial strains (Table 1) were routinely
grown in liquid or on solid (1.5% agar) Luria-Bertani (LB) medium at
28°C (Pseudomonas strains) or at 37°C (Escherichia coli [for transposon
mutagenesis]). When required, the medium was supplemented with
the following antibiotic(s): kanamycin (50 g·ml1), ampicillin
(50 g·ml1), or gentamicin (10 g·ml1). The basidiomycete R. solani
Ag3 and the oomycete P. aphanidermatum (Table 1) were used as target
pathogens in in vitro inhibition assays and soil microcosm experiments.
The fungus or oomycetewasmaintained on standard potato dextrose agar
(PDA; BD/Difco, USA) medium at 20°C.
Soil sampling, DNA isolation, and pyrosequencing analysis of the
Inneruulalik potato soil. For details on soil sampling,DNA isolation, and
pyrosequencing analysis of the Inneruulalik potato soil, see Materials and
Methods in the supplemental material.
Soil microcosm assays. The Inneruulalik soil was sieved (0.5-cm-
pore-size mesh) to remove plant debris and small stones. Tomato seeds
(cv. Marmande Super) were presprouted for 4 days at 20°C in petri dishes
on wetted filter paper.
For determination of soil suppressiveness, four presprouted tomato
seedlings were placed randomly in petri dishes filled with 40 g of soil with
an initial moisture content of 14.8% (vol/wt). The various soil treatments
were suppressive soil (S), suppressive soil heat-treated at 80°C in an oven
for 1 h (C), and heat-treated soil mixed with 10% (wt/wt) suppressive soil
(CS). R. solani Ag3 was introduced into the soil by transferring one quar-
ter of a mycelium agar plug (6-mm diameter) of a 1-week-old PDA plate
to each corner of a petri dish. Plates were incubated in a growth chamber
at 15°C using a 16-h:8-h light:dark cycle and watered after 1 week of
incubation with 5 ml of standard Hoagland solution (macronutrients
only). Four replicates (i.e., plates) were made for each soil treatment, and
the experiment was repeated twice. After 12 days of incubation, the per-
centage of infected tomato seedlings showing damping-off symptomswas
scored.
In order to determine the R. solani Ag3-suppressive activity by the
P. fluorescens In5 wild type and the P. fluorescens Tn1 mutant strain, soil
was initially heat-treated at 80°C in an oven for 1 h. Four presprouted
tomato seedlings were placed randomly in petri dishes filled with 40 g of
the heat-treated soil with or without addition (2 ml/100 g) of overnight
(O/N) bacterial cultures washed twice with LB and adjusted to an optical
density at 600 nm (OD600) of 2. R. solani Ag3 was introduced into the soil
as described above. The various soil treatments were control soil, tomato
seedlings only (C), soil inoculated with the P. fluorescens In5 wild type
(In5), soil inoculated with mutant strain P. fluorescens Tn1 (Tn1), soil
infected with R. solani Ag3 (R), soil inoculated with the P. fluorescens In5
wild type and infected withR. solaniAg3 (In5-R), and soil inoculated with
mutant strain P. fluorescens Tn1 and infected with R. solani Ag3 (Tn1-R).
Plates were incubated in a growth chamber at 15°C or 20°C with a 16-h:
8-h light:dark cycle. Plates were watered as described above. Four repli-
cates (i.e., plates) were made for each soil treatment, and the experiment
was repeated twice. After 10 and 6 days of incubation at 15°C and 20°C,
respectively, the percentage of infected tomato seedlings showing
damping-off symptoms was scored.
Screening of the transposon mutant library. Transposonmutagene-
sis of P. fluorescens In5 was performed using a mobilizable plasposon,
pTnModOKm (26), as previously described (27). Strain In5 transconju-
gants with transposons integrated into the chromosome were selected on
LB agar plates supplemented with kanamycin and ampicillin. Approxi-
mately 1,500 mutants were screened for lack of antifungal activity. Mu-
tants were grown O/N in F96 Microwell plate (Nunc) (in 150 l LB with
ampicillin [50 g·ml1 per well] and kanamycin [50 g·ml1 per well]).
Overnight cultures (1.5 l) were transferred by a multichannel pipette to
OmniTrays (Nunc) containing PDA at a strength of 1/5 (1/5 PDA) previ-
ously inoculated with a suspension of blended fungal hyphae of R. solani
Ag3 or P. aphanidermatum. Transposon rescue of selected mutants using
XhoI or SacII was performed as previously described (6).
Homologous recombination.Gene knockout by homologous recom-
bination in them/z 1,138 andm/z 2,060NRP gene clusters was carried out
using a gene replacement vector, pEX100T (28). Approximately 2,000 to
2,300 bp of them/z 1,138 andm/z 2,060NRP gene clusters containing one
or two SalI sites were amplified with primers NRPS13a (5=-CGCATAAC
CGCACACTG=-3) and NRPS13b (5=-CTGGAACAAGTCGGTCGC=-3)
and primers 2 F (5=-TGTCGAGGCTTGCGCCAAC=-3) and 2 R (5=-CG
CGGAAGCGGTGATCCT=-3), respectively. Them/z 1,138 andm/z 2,060
NRP gene fragments were amplified using Phusion blunt-end polymerase
(annealing temperature, 63°C), according to the manufacturer’s instruc-
tions. The blunt-end-amplified fragments were ligated into SmaI-
digested pEX100T. The pEX100T vectors with insertions were digested
with SalI, and a SalI-digested gentamicin resistance (Gmr) gene and a
promoter from plasmid Tn7gfp2 (29) were inserted into the NRP gene
clusters. The pEX100T vectors with NRP fragments disrupted by the Gmr
gene were transformed into electrocompetent P. fluorescens In5 cells to-
gether with the pUX-BF13 helper plasmid as previously described (30).
Strain In5 transformants with a site-directed knockout in one of the two
NRP gene clusters were selected on LB agar plates supplemented with
ampicillin and gentamicin.
Fungus/oomycete inhibition assays on agar plates. Antifungal activ-
ity of the different strains and the purified nunamycin and nunapeptin
was tested on 1/5 PDA against R. solani Ag3 or P. aphanidermatum. Ten
TABLE 1 Bacteria, fungi, and plasmids used in this study
Plasmid or bacterial or fungal strain Relevant genotype and (or) characteristic(s)a Reference
Plasmids
ppiKmLacZ Kmr-lacZ cassette; pTnMod-based; mobilizable 26
pRK2013 Self-transmissible helper plasmid; Kmr 27
pEX100T oriT, bla, sacB 28
Bacteria
Escherichia coli DH5 endA1 hsdR17 supE44 thi-1 recA1 U169 deoR 34
Pseudomonas fluorescens In5 WT 6
Pseudomonas fluorescens In5-Tn1 nunE 6
Pseudomonas fluorescens In5-Gr1 nunD This study
Pseudomonas fluorescens In5-Gr2 nupB This study
Pseudomonas fluorescens In5-Tn1Gr2 nunE nupB This study
Fungus or oomycete
Rhizoctonia solani Ag3 Basidiomycete 6
Pythium aphanidermatum Oomycete 6
a Km, kanamycin; WT, wild type.
Antifungal Peptides from Pseudomonas
March/April 2015 Volume 6 Issue 2 e00079-15 ® mbio.asm.org 7
 
m
bio.asm
.org
 o
n
 July 16, 2015 - Published by 
m
bio.asm
.org
D
ow
nloaded from
 
microliters of O/N bacterial cultures or 10g of the crude peptide extract
or purified nunamycin and nunapeptin peptides on sterile filter papers
was inoculated in the center of the agar plates. SterileMilliQ purifiedH2O
on filter paper was used as a control for the peptide extract and purified
peptides. Four fungus/oomycete mycelium plugs were placed 2 cm from
the center of the plate around the colony or filter paper. Plates were made
in triplicate and incubated at 15°C (P. aphanidermatum) or 20°C (R. solani
Ag3). Following 48 to 240 h of coculturing, depending on the fungus/
oomycete strain and incubation temperature used, all plates were visually
inspected and the inhibitory effect of the bacterial strains was evaluated as
percent inhibition of radial growth (PIRG) as previously described (31).
MALDI-TOF imaging mass spectrometry analysis. P. fluorescens In5
or mutant strain Tn1 or Gr1 was cocultured with R. solani Ag3 or
P. aphanidermatum on thin 1/5 PDA plates (i.e., 10 ml of media in a
standard petri dish, resulting in a thickness of medium of about 1.5 mm).
Once the desired time point for growth was reached, areas of agar media
containing the microbial colonies were excised from the petri dish and
transferred to the MALDI stainless steel target plate. The subsequent ma-
trix application was performed using a 53-m-pore-size test sieve; dry
matrix was deposited evenly across the sample surface until the desired
matrix thickness was achieved. The sample was dried O/N followed by
MALDI-TOF IMS analysis using a Bruker Microflex mass spectrometer.
Data were collected from 50 to 3,000 m/z at 80-Hz laser frequency at a
spatial resolution of 400musing a random-walk shot pattern. Data were
analyzed using theCompass 1.2 software suite (FlexImaging 2.0, FlexCon-
trol 3.0, and FlexAnalysis 3.0; Bruker Daltonics) as previously described
(32). The resulting mass spectrum was binned at 0.5-m/z increments and
manually inspected for masses of interest. Masses were visualized using
false coloring on an optical image of the original sample plate.
Peptide extraction. Plates with 1/5 PDA medium were inoculated
with P. fluorescens In5. After incubation for 48 h at room temperature, the
agar was sliced into small pieces and extracted with acidified deionized
water (pH 2) for 1 h at 28°C and 225 rpm in a 2.8-liter Erlenmeyer flask
followed by addition of n-butanol and incubation for 18 h at 28°C. The
n-butanol extract was separated from agar by cheesecloth filtration and
subsequently from cell debris by centrifugation (6,440  g, 10 min).
n-Butanol was removed with a rotovaporator (Buechi R-200). The crude
peptide extract was resuspended in 1 ml methanol and analyzed by
MALDI-TOFmass spectrometry (MS). The resuspended extract was cen-
trifuged for 2 min at 16,000  g, and the supernatant was placed on a
methanol-equilibrated Sephadex LH20 column (30 cm length). The pep-
tide extract was separated with a methanol mobile phase at a flow rate of
0.4 ml/min. Fractions of 7.5 ml were collected, lyophilized, and resus-
pended in 200 l methanol. Gel filtration fractions were analyzed by
MALDI-TOFMS for peptide content. Fractions of the peptide-containing
gel filtrationwere combined and concentrated by lyophilization. The pep-
tides were further purified by reversed-phase high-pressure liquid chro-
matography (HPLC) using an Agilent 1260 system equipped with a Phe-
nomenex Kinetex C18 column (4.6 mm by 15 cm). The peptides were
eluted from the column using a gradient of 10% acetonitrile containing
0.1% formic acid:90% water containing 0.1% formic acid to 90% aceto-
nitrile containing 0.1% formic acid:10% water containing 0.1% formic
acid over 45 min at a flow rate of 1.0 ml/min. Peaks for nunamycin and
nunapeptin were collected manually (24.6 min for nunamycin and mul-
tiple peaks between 35 and 40 min for the nunapeptin family of com-
pounds), after which they were lyophilized and stored at80°C.
NMR and tandem MS analysis. About 1 mg of nunapeptin at m/z
2,023 to 2,075 and about 100g of nunamycin atm/z 1,138were dissolved
in 40 l of deuterated methanol (CD3OD) for NMR data acquisition.
NMRspectrawere recorded on aBrukerAvance iii 600-Mhz spectrometer
with a 1.7-mm-diameterMicrobiologyCryoProbe at 298K,with standard
pulse sequences provided by Bruker. Structures were confirmed by anal-
ysis of 1D proton, 2D Cosy double-quantum filter (Dqf-Cosy), 2D 1H-
13C heteronuclear single-quantum coherence (HSQC), and 2D 1H-13C
heteronuclear multiple-bond correlation (HMBC) spectra. 2D 1H-13C
HMBC spectra were recorded with delays corresponding to a 2j or 3j H-C
coupling constant of 8 Hz and a 1j H-C coupling constant of 145 Hz. 2D
1H-13C multiplicity-edited HSQC spectra were recorded, with delays
corresponding to a 1j H-C coupling constant of 140 Hz. Spectra were
referenced to the methanol methyl resonance at 3.31 ppm.
Tandem mass spectrometry experiments were performed on a
Thermo LTQ fault-tolerant (FT) mass spectrometer (Thermo Electron
Corp., Bremen, Germany) equipped with a Diversa Nanomate electros-
pray source. Aliquots from solutions of purified nunapeptin and nuna-
mycin compounds were diluted in acetonitrile:0.1% formic acid (70:30
[vol/vol]). Electrospray parameters included a spray voltage of 1.40 kV,
heated inlet temperature of 200°C, nebulizing gas pressure of 40 lb/in2N2,
collision-induced dissociation energy of 25 V, and collision time of
500 ms. The instrument was operated in FTmode (peak resolution, 50 k)
for detection of parent (MS) and daughter (MS/MS) ion peaks.
MALDI-TOF mass spectrometry. MALDI-TOF MS was used to de-
tect target peptides in the crude peptide extract and fractions from gel
filtration and HPLC as well as peptide production over time in the time
course experiment. The sample wasmixed 1:1 with a saturated solution of
Universal MALDI matrix–70% acetonitrile containing 0.1% trifluoro-
acetic acid (TFA) and spotted on aBrukerMSP 96 anchor plate. The target
plate containing the samples was dried and inserted into a Microflex
Bruker Daltonics mass spectrometer. External calibration was done as
described for MALDI-TOF IMS. Mass spectra were obtained with the
FlexControl method as used for MALDI-TOF IMS and a single-spot ac-
quisition of 200 shots. Single-spotMALDI-TOFMSdatawere analyzed by
FlexAnalysis software.
Time course experiment of peptide production. Cultures of the
P. fluorescens In5 wild type and the mutant strains, P. fluorescens Tn1 and
Gr1, were inoculated on solid 1/5 PDA at 20°C and sampled at specific
time points. Samples for dry-droplet analysis of peptide production (m/z
1,138 and 2,060) byMALDI-MS were taken after 6, 12, 24, 36, 48, 72, and
96 h and after 7 days. A scrape of bacterial colonies was dissolved in 100l
of sterile deionized water. The bacterial suspension was mixed 1:1 with a
saturated solution of Universal MALDI matrix in 70% acetonitrile con-
taining 0.1% TFA and spotted on a Bruker MSP 96 anchor plate. MALDI
MS analysis was carried out as described above.
Statistical analysis. Tukey’s honestly significant difference (HSD) test
was used in conjunction with analysis of variance (ANOVA) in order to
evaluate the data from the in vitro inhibition andmicrocosm experiments
to identify means with significant differences. The tests were carried out
with R version 2.10.0 (33).
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